SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-23-006877
Filing Date
2023-05-05
Accepted
2023-05-05 08:00:19
Documents
14
Period of Report
2023-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp193258_6k.htm 6-K 11226
2 EXHIBIT 99.1 dp193258_ex9901.htm EX-99.1 103754
3 EXHIBIT 99.2 dp193258_ex9902.htm EX-99.2 17043
4 EXHIBIT 99.3 dp193258_ex9903.htm EX-99.3 9502
5 EXHIBIT 99.4 dp193258_ex9904.htm EX-99.4 8464
6 GRAPHIC image_001.jpg GRAPHIC 9960
7 GRAPHIC ex9902_001.jpg GRAPHIC 92057
8 GRAPHIC ex9902_002.jpg GRAPHIC 151444
9 GRAPHIC ex9902_003.jpg GRAPHIC 142685
10 GRAPHIC ex9902_004.jpg GRAPHIC 137184
11 GRAPHIC ex9903_001.jpg GRAPHIC 421727
12 GRAPHIC ex9903_002.jpg GRAPHIC 731205
13 GRAPHIC ex9904_001.jpg GRAPHIC 233699
14 GRAPHIC ex9904_002.jpg GRAPHIC 731195
  Complete submission text file 0000950103-23-006877.txt   3803564
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39071 | Film No.: 23891335
SIC: 2834 Pharmaceutical Preparations